Main Article Content
Objective: Aims of the study is to specify the significance of thiol/disulfide homeostasis in the aspect of gestational diabetes mellitus (GDM) and GDM-related complications.
Material and Methods: This study is a prospective review of the data of 61 healthy and non-pregnant women, 58 healthy pregnant women, and 62 pregnant women with GDM.
Results: The patients with gestational diabetes mellitus had significantly higher disulfide/native thiol and disulfide/total thiol concentrations than non-pregnant patients (p<0.001 for both) and healthy pregnant patients (p: 0.015 and p: 0.018, respectively). Besides, in GDM group had significantly lower native thiol/total thiol concentrations than non-pregnant patients and healthy pregnant patients (p<0.001 and p: 0.016, respectively). There were positive and significant correlations between disulfide levels and HbA1c concentrations (r=0.26, p: 0.042), and between disulfide and oral glucose tolerance test first hour concentrations (r=0.26, p: 0.039). The receiver operating characteristic curve analyses for native thiol, total thiol, and disulfide were unable to predict adverse perinatal outcomes in this cohort.
Conclusion: The significantly higher concentrations of disulfide/native thiol and disulfide/total thiol in women with GDM could be considered as the presence of increased oxidative stress. However, these markers failed to predict adverse perinatal outcomes.
Keywords: gestational diabetes mellitus; oxidative stress; perinatal outcome; pregnancy; thiol/disulfide homeostasis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
2. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2003;26(suppl 1):103-5.
3. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol 2013;122(2 Pt 1):406-16.
4. Yu ZB, Han SP, Zhu GZ, et al. Birth weight and subsequent risk of obesity: A systematic review and meta-analysis. Obes Rev 2011;12:525-42.
5. Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care 2010;33(3):676-82.
6. Getahun D, Nath C, Ananth CV, Chavez MR, Smulian JC: Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol 2008;198(5):521-5.
7. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358(19):1991-2002.
8. Gürlek B, Kale I. The prevalence of gestational diabetes mellitus who were admitted to a single center private hospital in Rize. JGON 2019;16(1):31-6.
9. Linnenkamp U, Guariguata L, Beagley J, et al. The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014;103(2):186-96.
10. Lappas M, Hiden U, Desoye G, et al. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal 2011;15:3061-100.
11. Ates I, Kaplan M, Inan B, et al. How does thiol/disulfide homeostasis change in prediabetic patients? Diabetes Res Clin Pract 2015;110:166-71.
12. Ates I, Kaplan M, Yuksel M, et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 2016;51:47-51.
13. Ozler S, Oztas E, Caglar Turhan A, et al. Thiol/disulfide homeostasis in predicting adverse perinatal outcomes at 24–28 weeks of pregnancy in gestational diabetes. J Matern Neonatal Med 2016;29:3699-705.
14. Cremers CM, Jakob U. Oxidant sensing by reversible disulfide bond formation. J Biol Chem 2013;288:26489-96.
15. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2011;30(11):1191-212.
16. Biswas S, Chida AS, Rahman I. Redox modifications of protein-thiols: Emerging roles in cell signaling. Biochem Pharmacol 2006;71(5):551-64.
17. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014;47(18):326-32.
18. Rodrigues F, de Lucca L, Neme WS, et al. Influence of gestational diabetes on the activity of δ-aminolevulinate dehydratase and oxidative stress biomarkers. Redox Rep 2018;23(1):63-7.
19. Karacay O, Sepici-Dincel A, Karcaaltincaba D, et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diabetes Res Clin Prac 2010;89(3):231-8.
20. Li H, Yin Q, Li N, et al. Plasma markers of oxidative stress in patients with gestational diabetes mellitus in the second and third trimester. Obstet Gynecol Int 2016;2016:3865454.
21. Yıldırım M, Türkyılmaz E, Demir-Cendek B, et al. Altered maternal serum dynamic thiol-disulfide interchange reactions in pregnant women with gestational diabetes mellitus. Gynecol Obstet Reprod Med 2016;22(3):129-34.
22. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int J Mol Med 1999;4(3):223-30.
23. López-Tinoco C, Roca M, García-Valero A, et al. Oxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus. Acta Diabetol 2013;50:201-8.
24. Zand H, Morshedzadeh N, Naghashian F. Signaling pathways linking inflammation to insulin resistance. Diabetes Metab Syndr 2017;11(1):307-9.
25. Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999;353:1649-52.
26. Rueangdetnarong H, Sekararithi R, Jaiwongkam T, et al. Comparisons of the oxidative stress biomarkers concentrations in gestational diabetes mellitus (GDM) and non-GDM among Thai population: cohort study. Endocr Connect 2018;7(5):681-7.